Notably, the downregulation of IRS1 in CCA cells resulted in a decrease in proliferation and block of cell cycle progression, together with a reduction of motility, invasiveness, oxidative stress resistance, and stemness features. This evidence concerns the gene IRS1 and cholangiocarcinoma.